Wikidata

(Q44333531)

English

Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study

scientific article

In more languages

Statements

title
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12610037
retrieved
2 December 2017
author name string
Jay M Young
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12610037
retrieved
2 December 2017
Jerome Fischer
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
12610037
retrieved
2 December 2017
Keith Bangerter
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12610037
retrieved
2 December 2017
Thomas Segerson
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12610037
retrieved
2 December 2017
Terry Taylor
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
12610037
retrieved
2 December 2017
Vardenafil Diabetes Study Group
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
12610037
retrieved
2 December 2017
publication date
1 March 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
12610037
retrieved
2 December 2017
page(s)
777-783
1 reference
stated in
Europe PubMed Central
PubMed ID
12610037
retrieved
2 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44333531&oldid=2018767292"